scholarly journals PCV39 COST-EFFECTIVENESS OF NIASPAN®VERSUS ZETIA® AS ADD-ON TREATMENTTO STATIN THERAPY IN HIGH-RISK PATIENTS

2008 ◽  
Vol 11 (6) ◽  
pp. A393
Author(s):  
SV Sorensen ◽  
SF Webb ◽  
RT Burge
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Statin Therapy ◽  
High Risk Patients ◽  
Risk Patients

scholarly journals Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients With Coronary Artery Disease

Circulation ◽  
2007 ◽  
Vol 115 (18) ◽  
pp. 2398-2409 ◽  
Author(s):  
Paul S. Chan ◽  
Brahmajee K. Nallamothu ◽  
Hitinder S. Gurm ◽  
Rodney A. Hayward ◽  
Sandeep Vijan
Keyword(s):  
Coronary Artery Disease ◽  
Cost Effectiveness ◽  
Coronary Artery ◽  
High Risk ◽  
Statin Therapy ◽  
High Dose ◽  
Incremental Benefit ◽  
High Risk Patients ◽  
Risk Patients ◽  
Artery Disease

PMD9 Cost-Effectiveness of an Antibacterial Envelope for Cardiac Electronic Implantable Devices in High-Risk Patients in the Public Sector in Mexico

2021 ◽  
Vol 24 ◽  
pp. S124-S125
Author(s):  
Balderrama V Jauregui ◽  
F. Lemus ◽  
B. Flores ◽  
A. Figueroa ◽  
J. Valencia ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Public Sector ◽  
High Risk ◽  
Implantable Devices ◽  
The Public ◽  
High Risk Patients ◽  
Risk Patients

scholarly journals The Cost-Effectiveness Of Tavi In Inoperable And High Risk Patients In France

2017 ◽  
Vol 20 (9) ◽  
pp. A589
Author(s):  
G Goodall ◽  
B Zemanova ◽  
P Candolfi ◽  
A Sohlberg
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
High Risk Patients ◽  
Risk Patients ◽  
The Cost

scholarly journals Cost-Effectiveness of Follow-Up for Subsolid Pulmonary Nodules in High-Risk Patients

2020 ◽  
Vol 15 (8) ◽  
pp. 1298-1305 ◽  
Author(s):  
Mark Morris Hammer ◽  
Lauren L. Palazzo ◽  
Adelle Paquette ◽  
Andrew L. Eckel ◽  
Francine L. Jacobson ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Pulmonary Nodules ◽  
High Risk Patients ◽  
Risk Patients
Sign in / Sign up

Export Citation Format

Share Document